Helsingen, Lise M;
Vandvik, Per Olav;
Jodal, Henriette C;
Agoritsas, Thomas;
Lytvyn, Lyubov;
Anderson, Joseph C;
Auer, Reto;
Murphy, Silje Bjerkelund;
Almadi, Majid Abdulrahman;
Corley, Douglas A;
Quinlan, Casey;
Fuchs, Jonathan M;
McKinnon, Annette;
Qaseem, Amir;
Heen, Anja Fog;
Siemieniuk, Reed A C;
Kalager, Mette;
Usher-Smith, Juliet A;
Lansdorp-Vogelaar, Iris;
Bretthauer, Michael;
Guyatt, Gordon.
Recent 15-year updates of sigmoidoscopy screening trials provide new evidence on the effectiveness of colorectal cancer screening. Prompted by the new evidence, we asked: “Does colorectal cancer screening make an important difference to health outcomes in individuals initiating screening at age 50 to 7...
Generar recomendaciones basadas en la mejor evidencia disponible acerca del manejo de personas
con sospecha o diagnóstico de cáncer de colon o recto....
OBJECTIVE: To estimate benefits and harms of different colorectal cancer screening strategies, stratified by (baseline) 15-year colorectal cancer risk. DESIGN: Microsimulation modelling study using MIcrosimulation SCreening ANalysis-Colon (MISCAN-Colon).SETTING: A parallel guideline committee (BMJ Rapid ...
Wolf, Andrew M. D;
Fontham, Elizabeth T. H;
Church, Timothy R;
Flowers, Christopher R;
Guerra, Carmen E;
LaMonte, Samuel J;
Etzioni, Ruth;
McKenna, Matthew T;
Oeffinger, Kevin C;
Shih, Ya-Chen Tina;
Walter, Louise C;
Andrews, Kimberly S;
Brawley, Otis W;
Brooks, Durado;
Fedewa, Stacey A;
Manassaram-Baptiste, Deana;
Siege, Rebecca L;
Wender, Richard C;
Smith, Robert A.
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimula...
Lugli, A;
Kirsch, R;
Ajioka, Y;
Bosman, F;
Cathomas, G;
Dawson, H;
El Zimaity, H;
Fléjou, J. F;
Hansen, T. P;
Hartmann, A;
Kakar, S;
Langner, C;
Nagtegaal, I;
Puppa, G;
Riddell, R;
Ristimäki, A;
Sheahan, K;
Smyrk, T;
Sugihara, K;
Terris, B;
Ueno, H;
Vieth, M;
Zlobec, I;
Quirke, P.
Tumor budding is a well-established independent prognostic factor in colorectal cancer but a standardized method for its assessment has been lacking. The primary aim of the International Tumor Budding Consensus Conference (ITBCC) was to reach agreement on an international, evidence-based standardized sco...
La guía se encuentra centrada en los siguientes tópicos: Generar recomendaciones para la detección temprana que ayuden a disminuir la incidencia de cáncer de colon y recto en individuos a riesgo promedio y grupos con factores de riesgo para cáncer colorrectalen Colombia. Generar recomendaciones para...
Generar recomendaciones para la detección temprana que ayuden a disminuir la incidencia de cáncer de colon y recto en individuos a riesgo promedio y grupos con factores de riesgo para cáncer colorrectal en Colombia.Generar recomendaciones para mejorar la calidad en el diagnóstico, tratamiento quirúr...
Gil Parada, Fabio Leonel;
Torres Amaya, Marcela;
Riveros Santoya, Sandra Viviana;
Castaño Llano, Rodrigo;
Ibáñez, Heinz;
Huertas Quintero, Margarita María;
Carmona, Rafael;
Pardo, Rodrigo;
Otero, William;
Sabbagh, Luis.
Objetivo: desarrollar una guía de práctica clínica con la evidencia más reciente para la tamización de cáncer de colon y recto en población asintomática de riesgo promedio, dirigida a pacientes, personal asistencial, administrativo y entes gubernamentales de cualquier servicio de atención en Col...
Alsanea, N;
Almadi, M. A;
Abduljabbar, A. S;
Alhomoud, S;
Alshaban, T. A;
Alsuhaibani, A;
Alzahrani, A;
Batwa, F;
Hassan, A. H;
Hibbert, D;
Nooh, R;
Alothman, M;
Rochwerg, B;
Alhazzani, W;
Morgan, R. L.
BACKGROUND: Colorectal cancer is the most common cancer among Saudi men and the third commonest among Saudi women. Given the predominance of colorectal cancer compared with other cancers in Saudi Arabia, context-specific guidelines are needed for screening. METHODS: Experts from the Saudi Society of Colo...
PURPOSE: The current incidence of cancer in the world is 14 million cases in 2012, with a mortality rate of 8.2 million in that year. The incidence of cancer in Spain exceeds 215,000 cases a year, and survival rates are the highest when compared to those of our neighbouring countries. Among the reasons f...
